Viyash Scientific profitability ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Returns
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
9.8%9.8%3.2%−5.3%−17.4%
7.2%7.2%2.1%−1.9%−8.2%
17.5%17.5%9.5%−0.0%−4.5%
7.6%8.2%6.0%−0.0%−3.5%
Margins
18.9%19.1%10.4%4.5%0.8%
12.3%12.3%6.2%−0.0%−3.1%
—17.3%52.6%−85.2%—
10.7%10.2%2.9%−4.0%−9.7%
6.8%6.6%2.1%−2.2%−8.6%
5.4%5.2%1.4%−2.6%−8.5%
5.5%5.5%2.9%−0.0%−4.9%
Additional
36.7%35.6%27.2%45.8%11.4%
—2.2%5.7%0.0%0.0%
9.8%9.6%3.0%−5.3%−17.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VIYASH₹224.55

Viyash Scientific Ltd.

· Pharma & Health
₹ CrorePeersAARTIDRUGSYATHARTHTHYROCARESUPRIYASTARSPARCSHILPAMEDRUBICONMcap ₹9,809 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity-17.42-5.293.229.819.81
Return on Assets-8.21-1.932.057.217.21
Return on Capital Employed-4.53-0.019.4817.5317.53
Return on Invested Capital-3.51-0.016.028.187.64
Margins
EBITDA Margin0.844.4810.4319.0818.86
Operating Margin-3.08-0.016.1512.2512.25
Incremental Operating Margin—-85.2252.5617.31—
Pretax Margin-9.69-3.992.8610.2010.73
Net Income Margin-8.58-2.162.086.576.79
Net Income to Common Margin-8.53-2.621.415.185.44
FCF Margin-4.88-0.022.855.505.50
Additional
Effective Tax Rate11.3945.8127.1935.6336.73
Dvd Payout Ratio-0.00-0.005.732.19—
Sustainable Growth Rate-17.42-5.293.049.609.81
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.